| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Aug―27 |
Exploring the Therapeutic Potential of Algerian Propolis: GC/MS Profiling, Protective Inclusion Complex, and In Silico Evaluation Against SARS-CoV-2 Main Proteases |
Zahra Toutou, Sofiane Fatmi, Nacera Chibani, Katarzyna Pokajewicz, Mohamed Skiba, Piotr P. Wieczorek, Mokrane Iguerouada |
| 2 |
[GO] |
2024―Jan―10 |
In silico prediction of preventive activities of bioactive hazelnut peptides against COVID-19 and Monkeypox 2022 |
Zeynep Saliha Güneş, Bilal Çakır, İbrahim Gülseren |
| 3 |
[GO] |
2022―Apr―19 |
Computational design of stapled peptide inhibitor against
SARS-CoV
-2 receptor binding domain |
Asha Rani Choudhury, Atanu Maity, Sayantani Chakraborty, Rajarshi Chakrabarti |
| 4 |
[GO] |
2021―Oct―14 |
Peptides and peptidomimetics as therapeutic agents for Covid-19 |
Achyut Dahal, Jafrin Jobayer Sonju, Konstantin G. Kousoulas, Seetharama D. Jois |
| 5 |
[GO] |
2021―Jan―13 |
Stapled
ACE2
peptidomimetics designed to target the
SARS-CoV
-2 spike protein do not prevent virus internalization |
Danielle C. Morgan, Caroline Morris, Amit Mahindra, Connor M. Blair, Gonzalo Tejeda, Imogen Herbert, et al. (+9) Matthew L. Turnbull, Gauthier Lieber, Brian J. Willett, Nicola Logan, Brian Smith, Andrew B. Tobin, David Bhella, George Baillie, Andrew G. Jamieson |
|
